Filing metadata

Accession number
0001062993-22-023351
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Dec 05, 2022
Reporting period
Dec 02, 2022
Description
Insider transaction

Explore SEC Filings Hub